Introduction
Chagas disease, the chronic cardiomyopathy caused by infection with the intracellular parasitic protozoan Trypanosoma cruzi, remains a major health problem in Central and South America [1] . Although acute Chagas disease may have a fatal outcome, the blood parasitemia, tissue parasite burden (liver, spleen, and heart), and the inflammatory sequel tend to subside with the onset of adaptive immunity. After several years of asymptomatic infection, approximately 30% of infected patients develop a chronic and progressive form of cardiomyopathy [2] . While not excluding a secondary pathogenic role for autoimmunity, studies in humans and animal models support the concept that parasite persistence in myocardial tissues is the primary cause of chronic immunopathology [3] [4] [5] [6] . Cohort studies with chagasic patients have linked chronic heart pathology to T H 1-type responses [7] , but this proposition was recently called into question by a report indicating that the frequency of IFN-c-producing effector/memory T cells is inversely correlated with the severity of chronic Chagas disease [8] . Animal model studies established that acquired resistance depends on development of serum antibodies as well as on
IFN-c-producing CD4
þ and CD8 þ T cells [9] [10] [11] [12] . Recent studies indicated that CCR5 has a suceptible phenotype, attributed to impaired recruitment of effector T cells to parasitized heart tissues [13, 14] . Although the dominant epitope specificities recognized by cytotoxic CD8 T cells are encoded by highly polymorphic genes [15] , it is still unclear how T. cruzi escapes from immune surveillance [16] [17] [18] .
In the present work, we set out to investigate the mechanims linking innate to adaptive immunity in the mouse model of T. cruzi infection. Early studies about innate resistance mechanisms indicated that macrophages upregulate nitric oxide (NO)-dependent trypanocydal responses [19] due to ligand-induced signaling of Toll-like 2 receptors (TLR2) [20, 21] or TLR4 [22] . More recently, Bafica et al. reported that macrophages sense T. cruzi DNA via triggering of intracellular TLR9 [23] . Interestingly, they showed that acute infection is more severe in TLR2 À/À TLR9 À/À mice than in TLR9 À/À mice or either TLR2
À/À - [23] or TLR4-deficient mice [22] , albeit not as much as in the overtly susceptible MyD88 À/À mice [24] . While not formally excluding an additive innate role for TLR4, these collective studies suggested that cooperative activation of TLR2 and TR9 may account for the bulk of protective IFN-c responses generated by MyD88-dependent signaling pathways [23, 24] . Of note, analysis of macrophage activation by MyD88-independent pathways revealed that TLR/TRIF coupling promotes NO-dependent microbicidal responses through upregulation of type I interferons [25, 26] . In spite of evidence that mice deficient in IL-12 [27] are highly susceptible to T. cruzi infection, it is still uncertain if induction of T H 1-responses is strictly dependent on dendritic cell (DC) maturation by TLRs/ MyD88-dependent pathways. Pertinently, it was reported that spleen cells from MyD88 À/À mice display small yet significant production of IL-12 and IFN-c [24, 28] . These observations imply that IL-12-dependent Th1 responses may be also controlled by MyD88-independent mechanisms, such as the NKT/CD1d pathway [29] , or by endogenously released bradykinin (BK), an endogenous danger signal driving DC maturation [30] [31] [32] . ''Kinins'', a small group of mediators related to the nonapeptide BK, activate immature DCs [30] as well as several other cell types through the binding to distinct subtypes of G-protein-coupled receptors: B 2 R (constitutive) and B 1 R (inducible) [33] [34] [35] [36] . The B 2 R agonists, BK or lysyl-BK (LBK), are proteolytically excised from an internal segment of their parental (glyco)proteins, high or low molecular weight kininogens, by plasma or tissue kallikreins, respectively [33] . In the settings of infections, however, kinins can be generated through the direct action of microbial cysteine proteases, such as gingipain of Porphyromonas gingivalis [37] and cruzipain (CZP), the major cysteine protease of T. cruzi [38] [39] [40] [41] . Using a subcutaneous model of T. cruzi infection, we recently demonstrated that trypomastigotes release kinins in peripheral tissues through the activity of CZP [31] . Once liberated from plasma borne-kininogens, the short-lived kinin peptides activate CD11c TCT started to die earlier (day 16) than wild-type mice and were all dead by day 27 ( Figure 1A , lower panel). We then studied the outcome of infection with the Brazil strain. The results ( Figure S1 ) show that wild-type mice displayed a relatively low blood parasitemia and the mortality rate did not exceed 20%. In contrast, the B 2 R À/À mice infected by Brazil strain developed increased blood parasitemia, and 80% of these animals were dead by day 28 ( Figure S1 ). We then further characterized the outcome of intraperitoneal infection with the Dm28c strain, using a lower inoculum (6 3 10 5 ). Analysis by real-time PCR (qPCR) showed that heart tissues of infected B 2 R À/À mice (14 d p.i.) contained approximately 5-fold higher content of parasite DNA as compared to wild-type heart ( Figure 1B) . Surprisingly, we found that the parasite tissue burden in the spleen was very low both in B 2 R þ/þ (0.30 6 0.09 fg/100 ng host DNA) and B 2 R À/À (0.46 6 0.21 fg/100 ng host DNA) mice ( Figure 1B (Figure 2A ). Controls showed that, in the absence of T. cruzi soluble Ag, there was no significant production of IFN-c by the splenocytes (Figure 2A mice rendered these recipient mice resistant to lethal infection (0% mortality, n ¼ 5; three independent experiments), as compared to non-manipulated B 2 R À/À mice (100% (B) Quantification of T. cruzi Dm28c in heart and spleen from infected animals as described above. qPCR was performed as described in Materials and Methods in 100 ng of total DNA at 14 d p.i. Bars represent an average of four to five animals per group 6 SD. p , 0.05 between tissue parasitism in heart from wild-type and B 2 R As mentioned earlier in this section, we found a 5-fold increase of T. cruzi DNA in the heart of B 2 R-deficient mice at day 14 p.i., as compared to wild-type heart ( Figure 1C ). In view of these findings, we set out to determine if cardiac tissues of wild-type and B 2 R À/À mice contained type-1 effector T cells. Recall assays (again using wild-type splenic CD11c þ DCs as APCs) showed that IFN-c production by Figure S2 ). Collectively, the data indicate that B 2 R drives IL-12 production by splenic DCs, at least at very early stages of the infection. We then carried out in vitro studies to verify if the parasites could induce the maturation of CD11c þ (splenic) DCs through the activation of the kinin/B 2 R signaling pathway. IL-12 production and surface expression of co-stimulatory proteins were used as read-out for DC maturation. FACS analyses showed that CD11c þ DCs (BALB/c) did not produce significant IL-12 levels in the absence of parasites ( Figure 7C ). In contrast, IL-12 production was drastically increased upon addition of exogenous BK (positive control) or TCT, whereas HOE-140 cancelled both stimuli ( Figure 7C ). Notably, TCT Figure 7D) . Controls in the absence of pathogen indicated that lisinopril or HOE-140 as such did not induce IL-12 production by DCs ( Figure 7C ). Additionally, DCs cultivated with either TCT or BK (positive control) displayed increased surface expression of CD40 and CD86 ( Figure 7E ). Of note, HOE-140 cancelled the phenotypic changes induced by TCT ( Figure 7E , upper and lower panels), while responses induced by BK were significantly reduced by this B 2 R antagonist ( Figure 7E, lower panel) .
Since TCT generate kinins via CZP while invading endothelial cells, we next asked if parasite cysteine proteases were required for DC activation. This question was addressed by pre-incubating TCT with methylpiperazine-Phe-homoPhe-vinylsulfone-benzene (VSPh), an irreversible inhibitor of CZP. After washing the VSPh-TCT, they were added to DC cultures. Whether using FACS and ELISA, we found that VSPh-TCT failed to drive significant IL-12 production by DCs ( Figure 7C and 7D) , adding weight to the concept that the parasite relies on CZP to generate the innate kinin stimuli.
In order to verify whether the B 2 R À/À CD11c þ DCs were fully capable of responding to TLR agonists, we compared the in vitro response profile induced by cytosine-phosphate-guanine (CpG) and LPS. As shown in Figure 7F , IL-12 responses were of the same magnitude as compared to wild-type C57BL/6 DCs. Moreover, HOE-140 did not interfere with wild-type DC responsiveness to CpG and LPS ( Figure 7F) . Notably, the magnitude of B 2 R À/À DC response to TCT was nearly 10% of IL-12 responses observed in wild-type CD11c þ DCs ( Figure 7F ).
As expected, TCT or BK elicited vigorous IL-12 production in CD11c þ DCs from wild-type mice. In both cases, the IL-12 response was partially blocked by HOE-140 ( Figure 7F ). In contrast, BK did not induce IL-12 in B 2 R À/À DCs ( Figure 7F ). The notion that the kinin-releasing trypomastigotes induce DC maturation through B 2 R is supported by the following experimental evidence. First, our in vitro studies showed that TCT vigorously induced IL-12 responses in splenic DCs originating from wild-type (C57BL/6) mice, while failing to activate B 2 R À/À DCs. Second, we demonstrated that HOE-140, a specific antagonist of B 2 R, efficiently blocked DC maturation (IL-12 induction, upregulation of CD80, CD86, and CD40). þ -Activated T Cells at Advanced Stages of Acute Infection Heart-derived T cells were stimulated with T. cruzi Ag (25 lg/ml) for 18 h at 37 8C and were stained for CD4 or CD8, IFN-c, and CD44 marker as described in Materials and Methods. Cells from B 2 R þ/þ mice were gated on CD4
IFN-c þ lymphocytes and examined for expression of CD44. Dot plot profiles (n ¼ 5 mice/group) are representative of results observed in two independent experiments. Column graphs (lower panel) indicate the mean 6 SD of the frequency of IFN-c-producing CD4 Furthermore, the irreversible inhibitor of CZP (K11777) mitigated the IL-12 stimulatory activity (B 2 R-driven) of TCT, thus implicating the major cysteine protease of T. cruzi in the kinin generation mechanism. Extending these observations to the in vivo settings, we then analyzed IL-12 production by splenic CD11c Although we cannot claim that conventional DCs are the primary or even unique in vivo targets of T. cruzi in the spleen, the above mentioned results support the concept that kinin-releasing pathogens may drive DC maturation in vivo through the activation of G-protein-coupled B 2 receptors [32] . Since lymphoid tissues are irrigated by non-fenestrated capillaries, we may predict that trypomastigotes invading the splenic stroma are faced with an abundant supply of bloodborne proteins, such as kininogens. Given biochemical evidence that interactions of high molecular weight kininogens with heparan sulfate proteoglycans potentiate the kininreleasing activity of CZP [40] , it is plausible that the extracellular trypomastigotes might promptly liberate these paracrine signaling peptides while moving through extracellular matrices, hence driving DC maturation via B 2 R [31, 32] .
At first sight, our finding that TCT induce DC maturation via the endogenous kinin/B 2 R pathway appears to conflict with the well-established concept that innate sentinel cells sense pathogens via pattern recognition receptors (PRRs), such as the members of the TLR family [28, 44] . Indeed, early studies of macrophage (IFN-c-primed) interaction with T. cruzi (Y strain) suggested that TLR2 and TLR4 ligands [20] [21] [22] [20] [21] [22] . The intertwined nature of the innate pathways controlling IL-12 production by APCs is illustrated by the recent demonstration [23] that T. cruzi DNA potently induces IL-12 production by mouse macrophages through the activation of TLR9. Given the evidence that DCs are parasitized by T. cruzi [45] , it will be interesting to determine if endogenous (BK/LBK) and exogenous (T. cruzi DNA) danger signals may activate their respective sensor receptors, B 2 R and TLR9, at distinct temporal stages (i.e., early and late) of intracellular infection.
While examining the frequencies of type-1 effectors in extra-lymphoid and lymphoid tissues of wild-type and B 2 R À/À -infected mice, we became aware that B 2 R deficiency affected the temporal and spatial distribution of IFN-c-producing CD4 þ and CD8 þ T cells. Recall assays performed at day 14 p.i.
revealed weakened IFN-c production by intracardiac CD4 þ and CD8 þ T cells isolated from B 2 R À/À mice. However, we found high and comparable frequencies of INF-c-producing T cells in the spleen of the same B 2 R À/À and wild-type mice.
Since the parasites are scarcely found in the spleens of wildtype and B 2 R À/À mice, we may infer that activation of the kinin/B 2 R pathway is dispensable for early induction of type-1 effectors in the spleen. Adoptive cell transfer studies are required to find out if the induction of these early type-1 effector T cells is controlled by MyD88-coupled pathways [24] , such as those triggered by TLR2/TLR9 [23] and/or by IL-1R/IL-18 R [44] . In addition, it is possible that IL-12 induction by the NKT/CD1 pathway [29] may also contribute to early development of type-1 effectors in lymphoid tissues. showing an inverse correlation between these two parameters at day 14 p.i. Although we cannot a priori assume that Ag specificities of T cells recruited to the heart of wild-type and B 2 R À/À mice at 14 d p.i. are necessarily the same, independent studies performed with the Brazil [46] and Y strain of T. cruzi [47] converged in appointing cytotoxic CD8 þ T cells as the key effectors controlling intracellular parasite outgrowth in cardiac tissues. So far, efforts to characterize the Ag specificity of intracardiac CD8 þ T cells in our infection model have been hampered by the findings that Dm28c T. cruzi strain did not present open reading frames for genes coding for ASP-2 antigens [48] , which in other systems provide dominant epitopes recognized by cytotoxic CD8 þ T cells [46, 47] . In spite of these limitations, it is conceivable that immunoregulatory dysfunctions were responsible for the weakened type-1 responses observed in peripheral T cells from B 2 R À/À mice.
For example, it is possible that the migratory competence of effector T cells generated in lymphoid tissues may depend on DC activation via the kinin/B 2 R pathway. Pertinently, recent analysis of the susceptible phenotype of CCR5 À/À mice infected with T. cruzi implicated this chemokine receptor in the recruitment of CD8 þ and CD4 þ effector T cells into infected heart [13, 14] . Given these precedent findings, it will be worthwhile investigating if B 2 R and CCR5 signaling, whether acting separately or in conjunction, might promote the migration of effector T cells to peripheral sites of infection, such as the heart. As the infection advanced (14!28 d), wild-type mice developed high frequencies of IFN-c-producing CD4 þ and CD8 þ effector T cells, both in the spleen and heart.
Interestingly, a significant proportion of these Ag-responsive T cells displayed activated (CD44 þ ) phenotypes. In contrast, B 2 R À/À mice showed negligible frequencies of activated type-1 effectors at day 28, both in spleen and heart. Of note, we found that the intracardiac CD4 þ and CD8 þ T populations recovered from the CD3 þ pool of B 2 R À/À mice were significantly contracted ( Figure 5 ). Considering that B 2 R À/À mice recovered the capacity to mount protective type-1 responses upon adoptive transfer of wild-type DCs, it is possible that maintenance of T cell homeostasis may depend, at least to some degree, on DC responses elicited by endogenously released kinins. Albeit speculative, this hypothesis is worth exploring in light of independent reports showing that aberrant T cell apoptosis is the primary cause of the immunoregulatory abnormalities underlying host susceptibility to acute infection by the Dm28c strain of T. cruzi [49] .
Another intriguing phenotypic characteristic of infected B 2 R À/À mice emerged when we monitored production of IL-17
and TNF-a in our recall assays. Unexpectedly, we found that the weakened T H 1 responses of B 2 R À/À CD4 þ T cells (whether isolated from the spleen/heart) at day 28 d p.i. was accompanied by upregulated production of IL-17 and TNF-a, two pro-inflammatory cytokines associated with the effector activity of T H 17 cells. Recently characterized as a separate lineage of pro-inflammatory T helper cells distinct from conventional T H 1 and T H 2 cells [42, 43] , T H 17 cells differentiate from naïve precursors under the critical influence of IL-6 and TGF-b1 [50] . It is also known that committed T H 17 cells depend on the IL-23 survival signal to develop their pro-inflammatory function in vivo [51] . Notably, at early stages of infection (14 d p.i.), there was no significant production of IL-17 and TNF-a by spleen-or heart-derived T cells from infected B 2 R À/À mice, whether detected by conventional recall assays or polyclonal activation with anti-CD3 antibodies (unpublished data). It is unclear why the T H 1/T H 17 balance was inverted as the acute infection progressed in B 2 R À/À mice.
Recently, IL-27 was identified as the cytokine that suppresses T H 17 differentiation driven by IL-6 and TGF-b via STAT-1, independently of IFN-c [50] . Interestingly, T. cruzi-infected WSX-1 mice (deficient in the IL-27Ra) [52] develop severe hepatic injury, correlating with overproduction of various pro-inflammatory cytokines, such as IL-6, TNF-a, and IFN-c [52] . Although T H 17 responses were not evaluated in T. cruziinfected WSX-1 mice, these animals strongly upregulated T H 2 cytokines [52] . However, we were unable to detect IL-4 production or IgG isotype switching in infected B 2 R À/À mice, indicating that these mice strains do not share the same phenotype. Importantly, the recovery of type-1 responses in DC recipient B 2 R À/À mice was associated with reduced production of IL-17 and TNF-a. Additional studies are underway to determine if DCs activated by the kinin/B 2 R pathway may influence T H 1/T H 17 lineage development in T. cruzi infection via IL-27, or through alternative mechanisms. Collectively, our results have linked development of acquired resistance to T. cruzi infection to DC functional responses controlled by the kinin/B 2 R signaling pathway. Our study provides a paradigm for investigations of the innate role of endogenously released kinin ''danger'' signals in T H 1/T H 17 development in other infections and inflammatory diseases.
(C) Intracellular IL-12 produced by splenic CD11c þ DCs of BALB/c mice incubated in vitro with 10 6 TCT or VSPh-TCT, ratio DC/TCT (1:3), in the presence or absence of 25 lM lisinopril (ACEi) for 18 h, and brefeldin A was added in the final 4 h. In same experiments, 10 nM BK was added to the medium, with or without 0.1 lM HOE-140, 10 lM VSPh, or 10 ng/ml LPS, as indicated. FACS profiles were done with CD11c-FITC and anti-IL12-PE. Each bar represents the % of DCs producing IL-12. Data represent the mean 6 SD from six independent experiments. Statistics were done by ANOVA and pair-wise comparisons ( HOE-140 (0.1 lM) in the presence of 25 lM of ACEi (lisinopril). Controls were also performed with LPS (10 ng/ml) and CpG (100 ng/ml) in the presence or absence of HOE-140 (0.1 lM). Data represent the mean 6 SD from three independent experiments done in triplicate each. Statistics were done by ANOVA and pair-wise comparisons were done by the Tukey tests (*, p , 0.05). doi:10.1371/journal.ppat.0030185.g007
Materials and Methods
Mice and parasites. Experiments were done with mouse strains BALB/c, C57BL/6 WT (B 2 R þ/þ ), and C57BL/6 B 2 R À/À [53] . TCT (Dm28c clone of T. cruzi) were harvested from the supernatants of infected LLC-MK2 cultures maintained in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 2% FCS. Freshly released parasites were washed 3X with excess PBS before being used in experiments. Epimastigotes (EPI) of Dm28c clone of T. cruzi were cultivated in standard liver infusion tryptose medium (LIT) containing 10% FCS (GIBCO). Where indicated, TCT were pre-incubated for 20 min at RT with 10 lM of VSPh.
In vitro activation of CD11c þ DC isolated from normal mouse spleen. Splenic DCs were isolated with anti-CD11c magnetic beads (Miltenyi Biotec) and stimulated in vitro with TCT (3 3 10 6 /well) in DMEM/10% fresh FCS for 18 h at 37 8C in the presence or absence of 25 lM lisinopril (Lis; Sigma), an inhibitor of the angiotensin converting enzyme (ACEi) and/or 0.1 lM HOE-140, as indicated. In some experiments, DCs were treated with VSPh-TCT. Controls were done with 10 nM BK, 10 ng/ml LPS, or 100 ng/ml CpG. For intracellular staining of IL-12, 1 3 10 6 DCs were washed and pre-incubated with 2% of normal mouse serum (NMS) supplemented with anti-mouse CD16/ CD32 FCc III/II receptor (clone 2.4G2) (1 lg/10 6 cells) (BD Biosciences). The washed cells were stained with anti-mouse CD11c-FITC (BD Biosciences) in PBS/2% NMS. After washing (2X PBS), the cells were fixed in 2% paraformaldehyde, washed, and permeabilized with 0.05% saponin (Sigma-Aldrich). Staining with PE-labeled anti-IL-12 p40/p70 (BD Biosciences) was performed in PBS/2% NMS/0.5% saponin. Surface expression of co-stimulatory proteins was monitored by incubating DCs with antibodies to CD40 or CD86 (BD Biosciences) in the presence of PBS/2% NMS. Isotype-matched control was performed with rat IgG-FITC or IgG 1 -PE (BD Biosciences). Samples were analyzed by (FACSCalibur) (BD Biosciences), and data analyses were done with CELLQuest software (BD Biosciences) or Win-MDI software (TSRI).
Isolation and characterization of DCs from mice infected with T. cruzi. Mice were pre-treated or not with 10 mg/kg intraperitoneally of ACEi (captopril) and/or 100 lg/kg subcutaneously of HOE-140, as indicated, and 1 h later the mice were injected intravenously with 1 3 10 6 TCT. DCs were isolated from spleen at 18 h p.i. Briefly, pooled lymph node fragments were treated with collagenase D (Sigma-Aldrich), and CD11c þ DCs were positively selected using magnetic beads covered with anti-mouse CD11c (Miltenyi Biotec; 90% pure). CD11c þ DCs (10 6 cells/well) were incubated for 4 h in RPMI complete medium with 10 lg/ml brefeldin A (Sigma-Aldrich) and were stained for CD11c and IL-12 p40/p70 as described above.
Cytokine production by spleen-and heart-derived T cells isolated from T. cruzi-infected mice. B 2 R þ/þ and B 2 R À/À mice were infected by the intraperitoneal route with 6 3 10 5 TCT. After 28 d, splenocytes were recovered and were stimulated with 25 lg/ml boiled soluble T. cruzi antigen (EPI-Ag). Total CD3 þ T cells (T cell Enrichment column; R&D Systems) were purified from either spleen or heart of infected B 2 -infected mice were killed at the time points indicated (14 d and 28 d p.i.) and single cell suspensions were prepared from the spleen and heart. Red blood cell-depleted cells were stimulated with 25 lg/ml boiled soluble T. cruzi antigen (EPI-Ag) and treated with anti-mouse CD16/CD32 FCc III/II receptor before staining. Cells were then fixed in 2% paraformaldehyde and stained with FITC-labeled mouse antibody against CD4 or CD8, and PE-Cylabeled mouse antibody against CD44 (BD Biosciences). For intracellular staining, stimulated cells were treated with brefeldin A (BD Biosciences) and stained with PE-labeled anti-IFN (XMG1.2; eBiosciences). Samples were analyzed by FACSCalibur (BD Biosciences), and data analyses were done with CELLQuest software (BD Biosciences).
Quantification of tissue parasite loads by qPCR. qPCR for parasite quantification was performed as described previously [54] with minor modifications. Briefly, DNA was isolated from spleen and heart tissues of B 2 R þ/þ and B 2 R À/À mice infected by the intraperitoneal route with 6 3 10 5 TCT, after digestion with proteinase K, followed by a phenolchloroform-isoamyl alcohol affinity extraction. q-PCR using 100 ng of total DNA was performed on an ABI PRISM 7900 sequence detection system (Applied Biosystems) using SYBR Green PCR Master Mix according to the manufacturer's recommendations. Purified T. cruzi DNA (American Type Culture Collection) was sequentially diluted for curve generation in aqueous solution containing equivalent amounts of DNA from uninfected mouse tissues. The equivalence of host DNA between samples was normalized by levels of genomic beta-2 microglobulin (B2m) gene in the same samples. The following primers were used for T. cruzi genomic DNA, TCZ, GCTCTTGCCCA CACGGGTGC (forward), and CCAAGCAGCGGATAGTTCAGG (reverse); and for genomic B2m, CTGAGCTCTGTTTTCGTCTG (forward) and TATCAGTCTCAGTGGGGGTG (reverse).
Quantitative determination of IFNc levels by qPCR. B 2 R þ/þ and B 2 R À/À mice were infected with 1 3 10 4 trypomastigotes of the Brazil strain. Hearts were obtained at 15 d and 30 d p.i. RNA from the tissues was isolated using the Trizol LS reagent following the manufacturer's protocol. Briefly, 5 ng of RNA was reverse-transcribed in a final volume of 20 ll using Superscipt II transcriptase (Invitrogen). The reverse transcription mixture consisted of 1 mM dNTPs (Pharmacia Biotech), 20 mM dithiothreitol, 50 mM Tris HCl (pH 8.3), 75 mM KCl, 3 mM MgCl2, 2 ng hexamer (Pharmacia Biotech), and 200 U of superscript RT RNase H-reverse transcriptase (Invitrogen). The reaction was incubated for 50 min at 42 8C. The qPCR primers for IFN-c were 59 forward GCGGCCTAGCTCTGAGACAA and 59 reverse GACTGTGCCGTGGCAGTAAC, which amplified the 97-bp IFN-c gene fragment. qPCR was carried out using magnesium chloride (2 mM), primers, and the PCR Sybr Green Master Mix (Roche Applied Science) in a final volume of 20 ll. The reaction conditions for qPCR used for quantification of IFN-c have been previously described [55] . A standard curve for the quantification of IFN-c was developed in the range of 0.5 pg pg using the primers at same conditions. The result was normalized using GAPDH mRNA for each sample. The primer sequence and the conditions used for the real-time PCR quantification were the same as previously published [55] . Figure S1 . Assessment of cytokine production by splenic and heart-derived CD4 þ and CD8 þ T cells isolated (28 d 
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